Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.

ClinicalTrials.gov ID: NCT00040183

Public ClinicalTrials.gov record NCT00040183. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 12, 2026, 3:16 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Placebo Controlled Study of OSI-774 (Tarceva (TM)) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer

Study identification

NCT ID
NCT00040183
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
OSI Pharmaceuticals
Industry
Enrollment
569 participants

Conditions and interventions

Interventions

  • Tarceva (erlotinib HCl, OSI-774) Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 120 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 28, 2001
Primary completion
Jan 14, 2004
Completion
Jan 14, 2004
Last update posted
Jan 9, 2018

2001 – 2004

United States locations

U.S. sites
60
U.S. states
30
U.S. cities
54
Facility City State ZIP Site status
Arizona Clinical Research Center Tucson Arizona 85715
Highlands Oncology Group Springdale Arkansas 72764
Alta Bates Comprehensive Cancer Center Berkeley California 94704
Loma Linda University Cancer Institute Loma Linda California 92354
Metropolitan Hematology/Oncology Medical Group, Inc. Los Angeles California 90057
UCLA Medical Center Los Angeles California 90095
Kaiser Permanente San Diego California 92120
DeQuattro Community Cancer Center Manchester Connecticut 06040
New Britain General Hospital New Britain Connecticut 06050
Eastern Connecticut Oncology Norwich Connecticut 06360-2910
Carl and Dorothy Bennett Cancer Center Stamford Connecticut 06902-3628
Florida Cancer Specialists Fort Myers Florida 34135-4251
Oncology Hematology Group of South Florida Miami Florida 33176
Ocala Oncology Ocala Florida 34474
Tampa General Hospital Tampa Florida 33606
Atlanta Cancer Center Atlanta Georgia 30342
Onc/Hem Associates of Central Illinois Peoria Illinois 61602
Hematology Oncology Associates of Illinois Skokie Illinois 60077
Carle Cancer Center Urbana Illinois 61801
University of Iowa Hospital & Clinics Iowa City Iowa 52242
University of Kansas Medical Center Kansas City Kansas 66160
University of Kentucky Lexington Kentucky 40536-0098
Norton Healthcare, Inc. Louisville Kentucky 40202
Mary Bird Perkins Cancer Center Baton Rouge Louisiana 70809
J Gurtler, Hematology and Oncology Metairie Louisiana 70006
Annapolis Medical Specialists Annapolis Maryland 21401
Sinai Hospital Baltimore Maryland 21215
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore Maryland 21231
St Elizabeth Medical Center Boston Massachusetts 01235
New England Medical Center Boston Massachusetts 02111
Berkshire Hematology & Oncology, PC Pittsfield Massachusetts 012018298
Baystate Medical Center Springfield Massachusetts 01107
University of Minnesota Minneapolis Minnesota 55455
Kansas City Oncology and Hematology Group Kansas City Missouri 64111
New Hampshire Oncology-Hematology PA Hooksett New Hampshire 03106
St Barnabas Medical Center Livingston New Jersey 07039
Arena Oncology Associates Great Neck New York 11021
New York University School of Medicine New York New York 10016
St Luke's-Roosevelt Hospital New York New York 10019
Interlakes Oncology & Hematology, P.C. Rochester New York 14623
Stony Brook University Hospital Stony Brook New York 11794-8174
Presbyterian Hospital Charlotte North Carolina 28204
Odyssey Research Services Bismarck North Dakota 58501
University Hospitals of Cleveland Cleveland Ohio 44106-7832
Chiles Research Cancer Center Portland Oregon 97213-2967
Hematology & Oncolgy Assoc of NE PA Dunmore Pennsylvania 18512
University of Pennsylvania Cancer Center Philadelphia Pennsylvania 19104
Pennsylvania Oncology Hematology Associates Philadelphia Pennsylvania 19106
Fox Chase Cancer Center Philadelphia Pennsylvania 19111
Charleston Hematology/Oncology Charleston South Carolina 29403
Sarah Cannon Cancer Center Nashville Tennessee 37203
Arlington Cancer Centre Arlington Texas 76012
Southwest Regional Cancer Center Austin Texas 78705
MD Anderson Cancer Center Houston Texas 77030
Tyler Hematology Oncology PA Tyler Texas 75701
Green Mountain Oncology Group Bennington Vermont 05201
Hematology & Oncology Associates of Virginia, Ltd. Richmond Virginia 23226
Western Washington Oncology Inc. Olympia Washington 98502
Southwest Washington Medical Center Vancouver Washington 98664
Oncology of Wisconsin Milwaukee Wisconsin 53215

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 80 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00040183, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 9, 2018 · Synced May 12, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00040183 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →